LipoScience Inc  

(Public, NASDAQ:LPDX)   Watch this stock  
Find more results for William N. Lucy
3.21
+0.15 (4.90%)
Apr 17 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range 3.07 - 3.22
52 week 2.92 - 9.85
Open 3.11
Vol / Avg. 35,214.00/96,607.00
Mkt cap 48.87M
P/E     -
Div/yield     -
EPS -0.65
Shares 15.22M
Beta     -
Inst. own 60%
May 5, 2014
Q1 2014 LipoScience Inc Earnings Release (Estimated) Add to calendar
Mar 12, 2014
LipoScience Inc at Barclays Healthcare Conference
Mar 10, 2014
Q4 2013 LipoScience Inc Earnings Conference Call
Mar 10, 2014
Q4 2013 LipoScience Inc Earnings Release
More events from DailyFinance »    

Key stats and ratios

Q3 (Sep '13) 2012
Net profit margin -36.32% 2.28%
Operating margin -32.81% 3.55%
EBITD margin - 6.04%
Return on average assets -24.93% 3.30%
Return on average equity -36.43% -
Employees 204 -
CDP Score - -

Address

2500 Sumner Blvd.
RALEIGH, NC 27616
United States - Map
+1-919-2121999 (Phone)
+1-302-6365454 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

LipoScience, Inc. is a vitro diagnostic company. The Company�s diagnostic test, the nuclear magnetic resonance (NMR) LipoProfile test, directly measures the number of low density lipoprotein (LDL), particles in a blood sample and provides physicians and their patients with actionable information to personalize management of risk for heart disease. The Company�s Vantera system is the Company's automated clinical analyzer. As of January 25, 2013, over eight million NMR LipoProfile tests were ordered. The Vantera system is its automated clinical analyzer. In August 2012, the Company received Food and Drug Administration (FDA) clearance to market the Vantera system commercially to laboratories.

Officers and directors

Buzz Benson Independent Chairman of the Board
Age: 58
Bio & Compensation  - Reuters
Howard B. Doran Jr. President, Chief Executive Officer, Director
Age: 52
Bio & Compensation  - Reuters
Lucy G. Martindale Chief Financial Officer, Executive Vice President
Age: 54
Bio & Compensation  - Reuters
James D. Otvos Ph.D. Chief Financial Officer, Executive Vice President
Age: 61
Bio & Compensation  - Reuters
Timothy J. Fischer Chief Operating Officer
Age: 51
Bio & Compensation  - Reuters
Kathryn F. Twiddy Vice President, General Counsel, Corporate Secretary
Bio & Compensation  - Reuters
E. Duffy McDonald Vice President - Human Resources and Organizational Effectiveness
Age: 60
Bio & Compensation  - Reuters
Thomas S. Clement Vice President - Regulatory and Quality Affairs
Age: 58
Bio & Compensation  - Reuters
William C. Cromwell M.D. Chief Medical Officer
Age: 46
Bio & Compensation  - Reuters
Jeffrey T. Barber Director
Age: 60
Bio & Compensation  - Reuters